Zensar Technologies Limited
501.20
INR
-8.15
(-1.60%)
ISIN
INE520A01027
Return %
Stock
S&P 500
1Y
-35.74
14.20
3Y
-2.00
81.12
5Y
2.84
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Manish Tandon
- Full Time Employees
- 10,779
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Zensar Knowledge Park Pune MA India 411014
- IPO Date
- Feb 10, 1995
- Website
- zensar.com
- Similar Companies
- Business
- Zensar Technologies Limited Zensar Technologies Limited (ZENSARTECH.NS) is a leading digital solutions and technology services company providing technology consulting, system integration, and IT services to enterprises worldwide. Headquartered in Pune, India, and founded in 2000 as a successor to operations tracing back to 1922, the company operates as a subsidiary of RPG Group and maintains a global footprint across more than 30 locations in North America, the United Kingdom, Europe, South Africa, and India, serving over 145 clients with a workforce exceeding 10,000 professionals. Zensar focuses on key industry verticals including banking, financial services and insurance (BFSI); hi-tech and manufacturing (HTM); consumer services such as retail and hospitality; and healthcare and life sciences, delivering tailored solutions through a global delivery model. The company's core products and services encompass application services including modernization, maintenance, and management; digital engineering and experience design; artificial intelligence and machine learning; cloud, infrastructure, and security management; data engineering and analytics; marketing and engagement platforms; enterprise integration via APIs and iPaaS; and industry-specific offerings such as Industry 4.0 solutions for manufacturing, omnichannel experiences for retail, core banking modernization for BFSI, and patient-centric solutions for healthcare. In recent developments, Zensar acquired BridgeView Life Sciences, LLC in July 2024 through its U.S. subsidiary to strengthen its healthcare and life sciences vertical, enhancing capabilities in biopharma cloud CRM, information management, analytics, program management, and partnerships with Veeva Systems, Reltio, Datavant, Snowflake, Salesforce, and IQVIA for pharmaceutical, biotechnology, and medical device clients. The company reported 4.0% year-over-year revenue growth in constant currency for Q2 FY25 ending September 2024, with sequential improvements in most portfolio areas, a record order book, EBITDA margin expansion to 15.4%, and strong collections reducing days sales outstanding to 71 days. Additional strategic moves include a global alliance with Saviynt for identity governance and privilege management, alongside wins in application modernization for sustainable technology and hospitality clients, SAP and AWS services for multinational firms, and IT operations transformation for UK banking.